In lipid-lowering trials, bile acid sequestrants, such as colesevelam, cholestyramine, colestipol, and colestimide, at maximum dose, lower LDL-C by 15–21%, and raise HDL-C by 3–9% and TG by 2 ...

Cholestyramine lowers LDL-C levels but ... Low doses of bile acid-binding resin (colestipol) associated with pravastatin was studied to evaluate the acceptability, compliance and short-term ...